Director, CHIEF EXECUTIVE OFFICER · PTC THERAPEUTICS, INC. · Common Stock
Side
SELL
Value
$202K
Shares
2,850
Price
$70.91
Executed
Apr 21, 2026
Disclosed
Apr 23, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 21 executedApr 23, 2026 disclosed
PTCT · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
4 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Klein Matthew B. filed this Form 4 reporting a open-market sale of PTCT on Apr 21, 2026. It became public on Apr 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CHIEF EXECUTIVE OFFICER
Klein Matthew B.cik:0001808968
Issuer
PTC THERAPEUTICS, INC.cik:0001070081
Revision history · 0
No field has changed since this record was first ingested.
